Published on 8 Apr 2024 on Zacks via Yahoo Finance

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Shares of this maker of infant formula, medical devices and drugs have returned -8.1% over the past month versus the Zacks S&P 500 composite's +2.6% change. The Zacks Medical - Products industry, to which Abbott belongs, has lost 0.5% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.